US-Canada joint inspection pilot shows savings of time-in-facility
This article was originally published in RAJ Devices
A US-Canada pilot programme involving joint quality systems inspections of medical device companies by a single third party has revealed that around 33% less total time is spent at a manufacturer's facility when compared to the combined time of inspections performed individually to satisfy the regulatory requirements of each country1,2.
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.